Harrell W Chesson

Author PubWeight™ 22.24‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2014 4.50
2 The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis 2013 2.39
3 Temporal trends in sexual behavior among men who have sex with men in the United States, 2002 to 2006-2010. J Acquir Immune Defic Syndr 2013 0.95
4 Using spatial regression methods to examine the association between county-level racial/ethnic composition and reported cases of Chlamydia and gonorrhea: an illustration with data from the state of Texas. Sex Transm Dis 2009 0.92
5 Years of potential life lost and productivity costs because of cancer mortality and for specific cancer sites where human papillomavirus may be a risk factor for carcinogenesis-United States, 2003. Cancer 2008 0.91
6 Chlamydia screening and pelvic inflammatory disease: Insights from exploratory time-series analyses. Am J Prev Med 2010 0.88
7 Linearity and nonlinearity in HIV/STI transmission: implications for the evaluation of sexual risk reduction interventions. Eval Rev 2011 0.87
8 Investigating the potential public health benefit of jail-based screening and treatment programs for chlamydia. Am J Epidemiol 2013 0.85
9 Aggregate versus individual-level sexual behavior assessment: how much detail is needed to accurately estimate HIV/STI risk? Eval Rev 2010 0.85
10 The economic burden of pediculosis pubis and scabies infections treated on an outpatient basis in the United States: evidence from private insurance claims data, 2001-2005. Sex Transm Dis 2009 0.85
11 Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data. Sex Health 2013 0.83
12 Assessment of the routine, occupation-based gonorrhea and syphilis screening program in Moscow, Russia: an analysis of sexually transmitted infection prevalence and cost-effectiveness. Sex Transm Dis 2008 0.82
13 The association between racial disparity in income and reported sexually transmitted infections. Am J Public Health 2013 0.82
14 Treatment cost of acute gonococcal infections: estimates from employer-sponsored private insurance claims data in the United States, 2003-2007. Sex Transm Dis 2010 0.80
15 Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States. Sex Transm Dis 2013 0.80
16 The concentration of sexual behaviours in the USA: a closer examination of subpopulations. Sex Transm Infect 2010 0.80
17 Decreases in AIDS mortality and increases in primary and secondary syphilis in men who have sex with men in the United States. J Acquir Immune Defic Syndr 2008 0.79
18 Medical costs of STDs. Perspect Sex Reprod Health 2009 0.78
19 Ciprofloxacin resistance and gonorrhea incidence rates in 17 cities, United States, 1991-2006. Emerg Infect Dis 2014 0.77
20 Cost effectiveness of one to one STI prevention interventions. Sex Transm Infect 2007 0.77
21 Cost-effectiveness of Chlamydia vaccination programs for young women. Emerg Infect Dis 2015 0.77
22 Racial Differences in Receipt of Chlamydia Testing Among Medicaid-Insured Women in 2013. Sex Transm Dis 2016 0.75
23 Sex in a lifetime: Sexual behaviors in the United States by lifetime number of sex partners, 2006-2010. Sex Transm Dis 2014 0.75
24 The consistency of relative incidence rates of nonviral sexually transmissible infections from health insurance claims and surveillance data, 2005-10. Sex Health 2013 0.75